Skip to main content
OpenTrials
Completed

NCT Number: NCT02210936

SCOSI-M: Preventing Prescription Drug Problems

Brandeis University and University of South Carolina (USC) have joined together to develop the South Carolina Opioid Safety Initiative - Military (SCOSI-M), to develop an academic detailing (medical education) intervention for physicians and evaluate its effectiveness in a pilot study. The goal of the intervention is to increase the use of safe prescribing and prescription monitoring practices among primary care physicians. The research team will design and pilot an educational intervention for physicians who treat military personnel, veterans, and their families with prescription opioids. The overall aim of SCOSI-M is to prevent the onset or progression of prescription drug problems among Iraq and Afghanistan veterans, military members, and their families who are at high risk for developing problems if their treatment involves long-term use of an opioid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prescription Drug Problems

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brandeis University

Waltham, Massachusetts, 02454, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a physician within one of the 3 practice environments;
  • typically prescribes Schedule II opioids to 10 or more non-cancer pain patients each month;
  • if community office-based, a substantial number of patients must have TRICARE (e.g., 20%); and d) willing to provide written consent for data collection and release of own SCRIPTS data.

Exclusion criteria

  • non-physician providers who report data to the SCRIPTS (dentist, veterinarians, nurses),
  • surgeons, pediatricians, or physicians predominately treating pain in cancer or surgical patients, and,
  • not eligible to register as authorized SCRIPTS user.

Treatment and study plan

Educational Intervention

Other

The design is primarily a pre-post, non-equivalent comparison group test of program effectiveness. If final sample size permits, we will examine program effects for each practice environment separately. For measures that require interview data there will be no comparison group data.

We will construct matched comparison groups of physicians for each environment for which only secondary data analysis will be conducted. The matched comparison group will be constructed using prescription data from the DoD's pharmacy data transaction system (MACH and DORN VAMC) and from SCRIPTS (community-based physicians and VA prescribers).

Primary outcomes

  1. Use of SCRIPTS

    Time frame: Up to 12 months

    Primary outcomes, or effectiveness, will be measured first by the use of SCRIPTS when prescribing opioids (e.g., % of new patients the physician queried; % of patients with long-term use the physician queried).

Sponsors and collaborators

Lead sponsor

Brandeis University

Other

Collaborators

  • Medical University of South Carolina
  • Moncrief Army Community Hospital
  • University of South Carolina
  • William Jennings Bryan Dorn VA Medical Center

Registry information

Official study title

Preventing Prescription Drug Problems: A Pilot Military Opioid Safety Initiative

Important dates

Study start
2014
Primary completion
2019
Study completion
2019
First posted
Aug 7, 2014
Registry last updated
Jul 9, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.